Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challenges
Acute otitis media (AOM) is among the most frequent childhood diseases and is caused by various bacterial and viral etiological agents. In this article, we provide an overview of published studies assessing the impact of higher-valent pneumococcal conjugate vaccines (PCVs) on AOM. In some instances, reports of PCV impact on complications of AOM have been included. While randomized controlled trials (RCTs) allow for the most precise assessment of vaccine efficacy against AOM, observational studies provide answers to questions regarding the public health value of these vaccines in real-life settings.
Source: International Journal of Pediatric Otorhinolaryngology - Category: ENT & OMF Authors: Ivo Vojtek, Marcus Nordgren, Bernard Hoet Tags: Review Article Source Type: research
More News: ENT & OMF | International Medicine & Public Health | Meningitis Vaccine | Otitis | Otitis Media | Pediatrics | Pneomococcal Vaccine | Study | Vaccines